Cases & Deals

Abbott and TAP Pharmaceutical settle NJ class action claiming violations of Prescription Drug Marketing Act in pricing Lupron®

Clients Abbott Laboratories and TAP Pharmaceutical Products Inc.

Jones Day represented Abbott Laboratories and TAP Pharmaceutical Products, Inc. in the defense of a New Jersey statewide class action alleging fraud, common law fraud and conspiracy in the pricing of its prostate cancer drug Lupron®.

Walker v. TAP Pharmaceutical Products et al. (N.J. Sup. Ct.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.